Loading stock data…
HCWB
$1.21+0.03 (+2.54%)
Market OpenUpdated 2:52 PM EDT
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States.
Historical Price
Price (Candle)
50-Day SMA
200-Day SMA
Whystock Brain
The Narrative
HCW Biologics Inc. in the Healthcare sector is trading at $1.21 with a market capitalization of $9M. Wall Street consensus targets $5.00 (1 analysts), implying a +313.2% move over the next 12 months. The stock is currently near its 52-week low of $0.25, remaining 38.9% below its 200-day moving average. On fundamentals, Piotroski 2/9 flags weak fundamentals, Altman Z in the distress zone. Risk note: RSI 27 is oversold, raising the odds of a near-term bounce; MACD remains below its signal line. The Whystock Score of 55/100 suggests a balanced risk-reward profile.
Ecosystem Influences
Sell-side targets imply +313.2% upside over 12 months
Long-term trend bearish (price vs 200-day SMA)
Oversold momentum (RSI 27) — potential for technical mean-reversion
Quarterly Financials
| Metric (USD) | Q1 2026 | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|---|
| Total Revenue | $6.54M↑ | $27,010↑ | $15,606↑ | $6,550↑ | $5,065 |
| Gross Profit | $6.53M↑ | $5,401↑ | $3,121↑ | $1,310↑ | $1,013 |
| Operating Income | $3.25M↑ | -$2.95M↑ | -$3.28M↑ | -$3.36M↓ | -$1.69M |
| Net Income | $3.47M↑ | $719,232↑ | -$4.55M↓ | -$1.93M↑ | -$2.20M |
Peer Comparison
JNJUNHPFE
Fundamentals
HCW Biologics Inc., a clinical-stage biopharmaceutical company, focuses on discovering and developing novel immunotherapies for chronic, low-grade inflammation, and diseases in the United States. Its lead products include HCW11-018b, a novel, tetra-v...
Market Cap
Total dollar market value of a company's outstanding shares of stock (Price * Shares).
$8.66M
P/E Ratio
Priced for growth. Investors expect sustained double-digit expansion.
-
Beta
High-beta play. Expect amplified moves vs. the broad market.
-
Div Yield
Low to zero yield. Return is entirely dependent on price appreciation.
0.00%
ROE
Average efficiency. Growth may require heavy reinvestment.
-39.75%
Volume
Today's trading volume
570,090
Recent News
Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
President Trump’s 12-word remark, “I don’t think about Americans’ financial situation, I don’t think about anybody,” hit the wires, and the reaction showed up in the forgotten corners of the market, where micro-cap turnarounds priced like option contracts ripped higher on May 15 as traders rotated into beaten-down names with operational catalysts already in motion. ... Trump Rattled Markets Again and These 3 Forgotten Stocks Under $30 Were the Unlikely Winners
BC-Most Active Stocks
YY Group Holdings Ltd. 26,117,734 0.0511
Wall Street Set to Open Little Changed Friday Ahead of Consumer Sentiment Report
US stocks look set to open little changed in Friday's trading session ahead of consumer sentiment da
Consumer Sentiment, Oil Inventory Reports Set for Release as US Futures Little Changed in Friday's Premarket Session
US stock futures were little changed in Friday's premarket session ahead of consumer sentiment and o
HCW Biologics Second Quarter 2025 Earnings: US$0.90 loss per share (vs US$16.16 loss in 2Q 2024)
NasdaqCM:HCWB 1 Year Share Price vs Fair Value Explore HCW Biologics's Fair Values from the Community and select yours...